Market closedNon-fractional
Boston Scientific/BSX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Boston Scientific
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Ticker
BSX
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Equipment and Supplies
Headquarters
Marlborough, United States
Employees
48,000
Website
www.bostonscientific.com
BSX Metrics
BasicAdvanced
$109B
Market cap
60.51
P/E ratio
$1.23
EPS
0.79
Beta
-
Dividend rate
Price and volume
Market cap
$109B
Beta
0.79
Financial strength
Total debt to equity
54.547
Interest coverage (TTM)
9.91%
Management effectiveness
Valuation
Price to earnings (TTM)
60.509
Price to revenue (TTM)
7.155
Price to book
5.48
Price to tangible book (TTM)
-368.84
Growth
Revenue change (TTM)
13.65%
Earnings per share change (TTM)
104.77%
3-year revenue growth (CAGR)
10.80%
3-year earnings per share growth (CAGR)
49.24%
What the Analysts think about BSX
Analyst Ratings
Majority rating from 34 analysts.
BSX Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$3.9B
3.52%
Net income
$494M
-2.18%
Profit margin
12.81%
-5.46%
BSX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.53
$0.50
$0.55
$0.56
-
Expected
$0.49
$0.48
$0.51
$0.51
$0.58
Surprise
8.27%
4.86%
7.37%
9.19%
-
BSX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Boston Scientific stock?
Boston Scientific (BSX) has a market cap of $109B as of July 26, 2024.
What is the P/E ratio for Boston Scientific stock?
The price to earnings (P/E) ratio for Boston Scientific (BSX) stock is 60.51 as of July 26, 2024.
Does Boston Scientific stock pay dividends?
No, Boston Scientific (BSX) stock does not pay dividends to its shareholders as of July 26, 2024.
When is the next Boston Scientific dividend payment date?
Boston Scientific (BSX) stock does not pay dividends to its shareholders.
What is the beta indicator for Boston Scientific?
Boston Scientific (BSX) has a beta rating of 0.79. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Boston Scientific stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.